US · Healthcare

Hansa Biopharma AB (publ) (HNSBF)

Biotechnology

Hansa Biopharma AB (publ) (HNSBF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HNSBF

P/E ratio

18.00

Hansa Biopharma AB (publ) (HNSBF) — FAQ

What is HNSBF's P/E ratio?

The price-to-earnings (P/E) ratio for Hansa Biopharma AB (publ) (HNSBF) is 18.00 (data as of 2026-03-24).

Does Hansa Biopharma AB (publ) pay a dividend?

Dividend yield is not available in the current snapshot for Hansa Biopharma AB (publ) (HNSBF). Check the MyAverix Finance app for the latest dividend data.

What sector is Hansa Biopharma AB (publ) in?

Hansa Biopharma AB (publ) (HNSBF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is HNSBF listed on?

HNSBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)